BAX - Baxter International Inc.

NYSE - NYSE Delayed Price. Currency in USD
75.10
+0.07 (+0.09%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Trade prices are not sourced from all markets
Previous close75.03
Open75.21
Bid75.14 x 800
Ask75.56 x 1000
Day's range74.89 - 75.54
52-week range61.05 - 82.25
Volume1,641,905
Avg. volume2,796,361
Market cap38.314B
Beta (3Y monthly)1.09
PE ratio (TTM)25.61
EPS (TTM)2.93
Earnings date25 Jul 2019
Forward dividend & yield0.76 (1.00%)
Ex-dividend date2019-06-06
1y target est82.93
  • Baxter (BAX) Down 1.5% Since Last Earnings Report: Can It Rebound?
    Zacksyesterday

    Baxter (BAX) Down 1.5% Since Last Earnings Report: Can It Rebound?

    Baxter (BAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Top Research Reports for Cigna, EOG Resources & Northrop Grumman
    Zacks17 days ago

    Top Research Reports for Cigna, EOG Resources & Northrop Grumman

    Top Research Reports for Cigna, EOG Resources & Northrop Grumman

  • Barrons.com17 days ago

    3 Stocks That Hiked Their Dividends This Week

    Synchrony Financial announced before the opening bell Thursday that it will increase its quarterly dividend by a penny, following dividend increases by Phillips 66 and Baxter International.

  • Business Wire18 days ago

    Baxter to Conduct Fixed Income Investor Presentations

    Baxter International Inc. (BAX), a leading global medical products company, today announced that representatives of the company will conduct a series of Fixed Income Investor Presentations on Thursday, May 9, 2019.

  • Baxter International Inc. (NYSE:BAX) Delivered A Better ROE Than Its Industry
    Simply Wall St.18 days ago

    Baxter International Inc. (NYSE:BAX) Delivered A Better ROE Than Its Industry

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Many investors are still learning about the various metrics that can be useful when analysing a stock...

  • BAX vs. CLPBY: Which Stock Is the Better Value Option?
    Zacks18 days ago

    BAX vs. CLPBY: Which Stock Is the Better Value Option?

    BAX vs. CLPBY: Which Stock Is the Better Value Option?

  • Business Wire19 days ago

    Baxter Named a “Best Company for Multicultural Women” by Working Mother

    Baxter International Inc. (BAX), a leading global medical products company, announced today that it has been named a 2019 Best Company for Multicultural Women by Working Mother magazine. This recognition is a result of the company’s sustained focus on supporting and advancing multicultural women at all levels of the organization globally.

  • Business Wire19 days ago

    Baxter Increases Dividend and Declares Quarterly Dividend

    Baxter International Inc. , a leading global medical products company, today announced an increase in the company’s quarterly cash dividend, to a rate of $0.22 per share of common stock.

  • Business Wire25 days ago

    Baxter to Present at the UBS Global Healthcare Conference

    Baxter International Inc. (BAX), a leading global medical products company, will present at the UBS Global Healthcare Conference on Monday, May 20, 2019 in New York. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time.

  • Business Wirelast month

    Baxter, NAACP and the Alliance for Home Dialysis Expand Program to Increase Awareness of Kidney Care among African Americans

    Baxter International Inc. (BAX), a global leader in renal care, along with the National Association for the Advancement of Colored People (NAACP) and the Alliance for Home Dialysis, today announced that the Dialysis Health Imperative for Access, Choice, and Equity (ACE) program will be expanded for a third year. This year, the program is expected to reach even more individuals and focus on driving awareness of kidney disease—including risk factors, prevention strategies and home dialysis treatment options—among the African American community.

  • Baxter International Inc (BAX) Q1 2019 Earnings Call Transcript
    Motley Foollast month

    Baxter International Inc (BAX) Q1 2019 Earnings Call Transcript

    BAX earnings call for the period ending March 31, 2018.

  • Baxter International Beats Expectations in Q1
    Motley Foollast month

    Baxter International Beats Expectations in Q1

    The medical products company delivered a solid performance to start off 2019.

  • Baxter (BAX) Q1 Earnings and Revenues Surpass Estimates
    Zackslast month

    Baxter (BAX) Q1 Earnings and Revenues Surpass Estimates

    Higher revenues, growth in APAC and strong operating margin benefit Baxter's (BAX) Q1 earnings. However, weak performance at Medication Delivery and Clinical Nutrition remains a concern.

  • Baxter (BAX) Beats on Q1 Earnings and Revenue Estimates
    Zackslast month

    Baxter (BAX) Beats on Q1 Earnings and Revenue Estimates

    Baxter International Inc. (BAX) reports solid Q1 performance on the back of higher revenues and strong operating margin.

  • Associated Presslast month

    Baxter: 1Q Earnings Snapshot

    On a per-share basis, the Deerfield, Illinois-based company said it had net income of 66 cents. Earnings, adjusted for non-recurring costs, came to 76 cents per share. The results beat Wall Street expectations. ...

  • Business Wirelast month

    Baxter Reports First-Quarter 2019 Results

    DEERFIELD, Ill.-- -- First-quarter revenue of $2.6 billion declined 2 percent on a reported basis and increased 2 percent on an operational basis First-quarter GAAP earnings per share of $0.66; Adjusted EPS of $0.76 increased 9 percent Company now expects full-year 2019 Adjusted EPS of $3.27 to $3.35 1 Baxter International Inc. , a leading global medical products company, today reported results for ...

  • Why the Earnings Surprise Streak Could Continue for Baxter (BAX)
    Zackslast month

    Why the Earnings Surprise Streak Could Continue for Baxter (BAX)

    Baxter (BAX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

  • What Makes Baxter (BAX) a New Buy Stock
    Zackslast month

    What Makes Baxter (BAX) a New Buy Stock

    Baxter (BAX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).

  • Can Core Renal Care Unit Drive Baxter's (BAX) Q1 Earnings?
    Zackslast month

    Can Core Renal Care Unit Drive Baxter's (BAX) Q1 Earnings?

    Strong performance across Renal Care, Clinical Nutrition, Advanced Surgery and Acute Therapies businesses might aid Baxter (BAX) in Q1. However, lower sales at Pharmaceutical business might be a woe.

  • Analysts Estimate Baxter International (BAX) to Report a Decline in Earnings: What to Look Out for
    Zackslast month

    Analysts Estimate Baxter International (BAX) to Report a Decline in Earnings: What to Look Out for

    Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Why Qualcomm Is among Steve Cohen’s Top Bets
    Market Realistlast month

    Why Qualcomm Is among Steve Cohen’s Top Bets

    Could Apple and Qualcomm’s Settlement Mean Upside for Point72?Steve Cohen’s Point72 Management Steve Cohen is a very high-profile investor whose SAC capital returned 30% annually for more than 20 years. In 2012, the firm was found guilty of

  • Business Wirelast month

    Baxter to Present at the Bank of America Merrill Lynch Health Care Conference 2019

    Baxter International Inc. (BAX), a leading global medical products company, will present at the 2019 Bank of America Merrill Lynch Health Care Conference in Las Vegas on May 15, 2019. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 8:40 a.m. Pacific Time. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.

  • How Baxter International Inc. (NYSE:BAX) Could Add Value To Your Portfolio
    Simply Wall St.last month

    How Baxter International Inc. (NYSE:BAX) Could Add Value To Your Portfolio

    Baxter International Inc. (NYSE:BAX) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In the case of BAX, it...

  • Business Wire2 months ago

    Baxter Unveils the Latest Evolution of Floseal at AORN Meeting

    Baxter International Inc. (BAX), a global leader in advancing surgical innovation, today announced that it has received U.S. Food and Drug Administration (FDA) approval for faster preparation of its leading hemostatic product, Floseal Hemostatic Matrix, at the 2019 Association of periOperative Registered Nurses (AORN) Global Surgical Conference and Expo. This next generation of Floseal has 20 percent fewer components and steps to prepare,1 making it easier and faster for operating room (OR) nurses to get Floseal in the hands of surgeons to help stop bleeding during procedures. The new design will be on display at Baxter’s AORN booth #1624.

  • Business Wire2 months ago

    Baxter to Host Webcast of Annual Meeting of Stockholders

    Baxter International Inc. (BAX), a leading global medical products company, will host a webcast of its Annual Meeting of Stockholders on Tuesday, May 7, 2019 at 9 a.m. Central Daylight Time. The live webcast of Baxter’s presentation along with the accompanying slides will be accessible from Baxter’s website at www.baxter.com.